JP2021511351A5 - - Google Patents

Info

Publication number
JP2021511351A5
JP2021511351A5 JP2020540565A JP2020540565A JP2021511351A5 JP 2021511351 A5 JP2021511351 A5 JP 2021511351A5 JP 2020540565 A JP2020540565 A JP 2020540565A JP 2020540565 A JP2020540565 A JP 2020540565A JP 2021511351 A5 JP2021511351 A5 JP 2021511351A5
Authority
JP
Japan
Prior art keywords
diazaspiro
cyclopropane
bicyclo
octane
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020540565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021511351A (ja
JP7273420B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/073000 external-priority patent/WO2019144912A1/zh
Publication of JP2021511351A publication Critical patent/JP2021511351A/ja
Publication of JP2021511351A5 publication Critical patent/JP2021511351A5/ja
Application granted granted Critical
Publication of JP7273420B2 publication Critical patent/JP7273420B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020540565A 2018-01-25 2019-01-24 β-ラクタマーゼ阻害剤及びその用途 Active JP7273420B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/074185 2018-01-25
CN2018074185 2018-01-25
PCT/CN2019/073000 WO2019144912A1 (zh) 2018-01-25 2019-01-24 β-内酰胺酶抑制剂及其用途

Publications (3)

Publication Number Publication Date
JP2021511351A JP2021511351A (ja) 2021-05-06
JP2021511351A5 true JP2021511351A5 (enExample) 2023-03-13
JP7273420B2 JP7273420B2 (ja) 2023-05-15

Family

ID=67394549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540565A Active JP7273420B2 (ja) 2018-01-25 2019-01-24 β-ラクタマーゼ阻害剤及びその用途

Country Status (8)

Country Link
US (1) US11078202B2 (enExample)
EP (1) EP3744722A4 (enExample)
JP (1) JP7273420B2 (enExample)
KR (1) KR102769880B1 (enExample)
CN (1) CN111670187B (enExample)
AU (1) AU2019211693B2 (enExample)
CA (1) CA3089150A1 (enExample)
WO (1) WO2019144912A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102769880B1 (ko) 2018-01-25 2025-02-20 쑤저우 시노벤트 파마슈티칼즈 씨오., 엘티디. β-락타마제 억제제 및 그 용도
CA3238268A1 (en) 2021-11-17 2023-05-25 Xufan WANG ?-lactamase inhibitor intermediate and preparation method therefor
CN117186107A (zh) * 2022-05-31 2023-12-08 成都先导药物开发股份有限公司 一种制备2-取代-5,7-二羰基-2,6-二氮杂螺[3,4]辛烷中间体的方法
WO2024160247A1 (zh) 2023-02-02 2024-08-08 苏州信诺维医药科技股份有限公司 含β-内酰胺酶抑制剂的药物组合物及其应用
CN116730941B (zh) * 2023-06-15 2024-07-02 广东省科学院微生物研究所(广东省微生物分析检测中心) 5-苯基-1,3,4-恶二唑类化合物及其制备方法和应用
CN118453513B (zh) * 2024-05-23 2025-06-17 苏州信诺维医药科技股份有限公司 一种β-内酰胺酶抑制剂液体制剂的制备工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1098129A (en) 1910-04-05 1914-05-26 John Thomas Simpson Aeroplane.
US1033000A (en) 1910-12-14 1912-07-16 Joseph Leslie Forster Pneumatic piano-player.
US1337809A (en) 1917-06-22 1920-04-20 Winton Alexander Protecting means for vessels
JP5038509B2 (ja) * 2008-01-18 2012-10-03 メルク・シャープ・エンド・ドーム・コーポレイション β−ラクタマーゼ阻害剤
CN103649088B (zh) * 2011-08-30 2016-05-11 沃克哈特有限公司 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途
TW201343645A (zh) 2012-03-30 2013-11-01 Cubist Pharm Inc 1,3,4-□二唑及1,3,4-噻二唑β-內醯胺酶抑制劑
JP2015512419A (ja) * 2012-03-30 2015-04-27 キュービスト ファーマシューティカルズ, インコーポレイテッド イソオキザゾールβ−ラクタマーゼ阻害剤
WO2014141132A1 (en) * 2013-03-14 2014-09-18 Naeja Pharmaceutical Inc. NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
CN106211771A (zh) 2014-01-21 2016-12-07 沃克哈特有限公司 含氮化合物及其作为抗菌剂的用途
IN2014MU01196A (enExample) 2014-03-29 2015-10-02 Wockhardt Ltd
EP3131583A1 (en) 2014-04-18 2017-02-22 The Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
WO2015173663A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited A process for preparation of trans-sulfuric acid mono-{2-[5-(2-methylamino-ethyl)-[1,3,4]-oxadiazol-2-yl]-7-oxo-1,6-diaza-bicyclo [3.2.1]oct-6-yl} ester
WO2015173665A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited A process for preparation of trans-sulfuric acid mono-{2-[5-(3-azetidinylamino)-methyl-[1,3,4]- oxadiazol-2-yl]-7-oxo-1,6-diazabicyclo[3.2.1] oct-6-yl} ester trifluoroacetate
CN108137567A (zh) 2015-10-02 2018-06-08 乐高化学生物科学股份有限公司 用于抑制β-内酰胺酶的组合物和方法
KR102769880B1 (ko) 2018-01-25 2025-02-20 쑤저우 시노벤트 파마슈티칼즈 씨오., 엘티디. β-락타마제 억제제 및 그 용도

Similar Documents

Publication Publication Date Title
US7582659B2 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
CN111670187A (zh) β-内酰胺酶抑制剂及其用途
CN103649088B (zh) 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途
US20150018312A1 (en) Nitrogen containing compounds and their use
SI2182950T1 (en) Use of 4- (pyrrolidin-1-yl) quinoline compounds for killing clinically latent microorganisms
US20070185132A1 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo
US6686363B2 (en) Cyclopropyl containing oxazolidinone antibiotics and derivatives thereof
US10273235B2 (en) Compositions and methods for inhibiting β-lactamase
US6927229B2 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
TW382625B (en) Cis-substituted fluoromethylpyrrolidine derivative
US20060247286A1 (en) Oxazolidinone antibiotics and derivatives thereof
JP2007521284A (ja) オキサゾリジノン系抗生物質及びその誘導体
US20070004712A1 (en) Salts of novel heterocyclic compounds having antibacterial activity
US20040072842A1 (en) Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent